We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Proton Pencil Beam Scanner Installed at US University Hospital

By HospiMedica International staff writers
Posted on 11 Apr 2017
The first installation of a novel, advanced, proton-therapy pencil beam scanning system that provides a new standard of Intensity Modulated Proton Therapy (IMPT) for cancer treatments, has taken place in a university hospital in the US.

The new standard combines fast energy-modulation with a sharp lateral penumbra, and is intended to improve treatment options for cancer patients.

The Mevion Medical Systems MEVION S250i with HYPERSCAN system was installed at the MedStar Georgetown University Hospital. More...
A second system will be installed in a Netherlands’ clinic, and another in a cancer center in Florida, in the US.

The system uses Mevion Medical System’s proton multi-leaf collimator called Adaptive Aperture, a low-profile system designed specifically for the new MEVION S250i scanner. The system provides layer-by-layer beam collimation and can achieve collimated effective spot sizes of one to three millimeters, for all energies. The new system can be used to scan a typical lung tumor within two seconds or less, eliminating patient motion artifacts.

The MEVION S250mx is a scalable proton therapy solution for two to four-room designs that provide redundancy and 100% uptime. The MEVION S250i system with HYPERSCAN and Adaptive Aperture is currently pending clearance by the US FDA for clinical use.

President and CEO of Mevion Medical Systems, Joseph K. Jachinowski, said, "Mevion is proud to be working with MedStar Georgetown to achieve this milestone, and to be making proton therapy accessible to the Washington D.C. area. HYPERSCAN with Adaptive Aperture represents a real paradigm shift for the entire industry. This is the only proton system able to precisely shape each energy layer and deliver those layers at speeds up to 50 times faster than other systems. The results are highly conformal proton dose distributions that can be automatically adapted as treatment progresses."


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Radiology System
Riviera SPV AT
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.